Nintedanib Slows Interstitial Lung Disease in Patients With RA Nintedanib Slows Interstitial Lung Disease in Patients With RA

Nintedanib slowed progression of interstitial lung disease associated with rheumatoid arthritis in a subgroup analysis of a phase 3 trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news